Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Iradimed (IRMD) Equity Ratio (2016 - 2025)

Iradimed (IRMD) has disclosed Equity Ratio for 13 consecutive years, with 0.86 as the latest value for Q3 2025.

  • On a quarterly basis, Equity Ratio fell 3.16% to 0.86 in Q3 2025 year-over-year; TTM through Sep 2025 was 0.86, a 3.16% decrease, with the full-year FY2024 number at 0.88, up 13.93% from a year prior.
  • Equity Ratio was 0.86 for Q3 2025 at Iradimed, down from 0.89 in the prior quarter.
  • In the past five years, Equity Ratio ranged from a high of 0.89 in Q2 2025 to a low of 0.77 in Q4 2023.
  • A 5-year average of 0.86 and a median of 0.87 in 2021 define the central range for Equity Ratio.
  • Peak YoY movement for Equity Ratio: fell 10.05% in 2023, then grew 13.93% in 2024.
  • Iradimed's Equity Ratio stood at 0.87 in 2021, then decreased by 1.07% to 0.86 in 2022, then decreased by 10.05% to 0.77 in 2023, then rose by 13.93% to 0.88 in 2024, then dropped by 2.91% to 0.86 in 2025.
  • Per Business Quant, the three most recent readings for IRMD's Equity Ratio are 0.86 (Q3 2025), 0.89 (Q2 2025), and 0.89 (Q1 2025).